Zenas BioPharma, Inc. (ZBIO) Stock Research

Zenas BioPharma, Inc.

· ZBIO

Dashboard

Financials

Ratios

Valuation

Statistics

1.744 B

+0.78%

Today

Zenas BioPharma price target raised by $7 at Citi, here's why

ZBIO

10:05 AM

Over a week ago

Zenas BioPharma announces new data from Phase 3 INDIGO trial on obexelimab

ZBIO

Sep 22, 7:24 AM

Wedbush biotech analyst holds an analyst/industry conference call

Sep 21, 9:53 AM

Zenas BioPharma files to sell 7.0M shares of common stock for holders

ZBIO

Sep 11, 4:50 PM

Zenas BioPharma price target raised by $10 at Morgan Stanley

ZBIO

Aug 17, 9:04 AM

Zenas BioPharma price target raised by $10 at Morgan Stanley, here's why

ZBIO

Aug 14, 8:43 AM

Zenas BioPharma CFO Jennifer Fox to transition out of role

ZBIO

Aug 13, 7:36 AM

Zenas BioPharma reports Q2 EPS ($1.77), consensus (75c)

ZBIO

Aug 13, 7:34 AM

Zenas BioPharma submits BLA to FDA for obexelimab

ZBIO

May 28, 7:23 AM

Zenas BioPharma price target raised by $1 at Morgan Stanley

ZBIO

May 14, 8:15 AM

Citi opens 'upside 30-day catalyst watch' on Zenas BioPharma

ZBIO

May 14, 5:51 AM

Zenas BioPharma doses first patient in Phase 1 clinical trial of ZB021

ZBIO

May 13, 6:51 AM

Zenas BioPharma reports Q1 EPS ($1.46) vs. (80c) last year

ZBIO

May 13, 6:05 AM

Zenas BioPharma director buys $1.5M in common stock

ZBIO

Mar 31, 7:44 PM

Zenas BioPharma 5M share Spot Secondary priced at $20.00

ZBIO

Mar 27, 7:48 AM

Closing Bell Movers: Argan jumps 10% on earnings beat

Mar 26, 7:03 PM

Zenas announces common stock, convertible senior notes offerings

ZBIO

Mar 26, 4:08 PM

Zenas BioPharma price target raised by $10 at Guggenheim, here's why

ZBIO

Mar 17, 7:04 AM

Zenas BioPharma price target raised by $2 at Morgan Stanley, here's why

ZBIO

Mar 17, 6:18 AM

Zenas BioPharma price target lowered by $2 at Citi, here's why

ZBIO

Mar 17, 5:50 AM

Morning Movers: National Storage surges following Public Storage buyout

Mar 16, 8:59 AM

Zenas BioPharma sees cash runway into 4Q27

ZBIO

Mar 16, 7:02 AM

Zenas BioPharma reports Q4 EPS ($4.54) vs. ($1.26) last year

ZBIO

Mar 16, 7:01 AM

Zenas BioPharma added to Best Ideas List at Wedbush

ZBIO

Feb 18, 6:52 AM

Zenas BioPharma says obexelimab met primary endpoint in Phase 2 study

ZBIO

Feb 9, 7:12 AM

Charts